Previous studies have shown that ANGPTL4 had higher expression in tumor patients and induced a malignant phenotype of tumor cells, i.e., proliferation, migration, and drug resistance [10, 12, 29, 30]. This evidence concerns the gene ANGPTL4 and neoplasm.